Your browser doesn't support javascript.
loading
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Zhao, Sizheng Steven; Harrison, Stephanie R; Chan, Antoni; Clarke, Nick; Davis, Charlotte; Eddison, Joe; Gregory, William J; Jones, Gareth T; Marzo-Ortega, Helena; Murphy, Daniel J; Sandhu, Virinderjit; Sengupta, Raj; Siebert, Stefan; Thompson, Ben; Webb, Dale; Yates, Max; Gaffney, Karl.
Afiliação
  • Zhao SS; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Harrison SR; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Chan A; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Clarke N; Department of Rheumatology, Royal Berkshire NHS Foundation Trust, Reading, UK.
  • Davis C; Patient Expert.
  • Eddison J; Department of Rheumatology, Leeds Teaching Hospitals Trust, UK.
  • Gregory WJ; Patient Expert.
  • Jones GT; Rheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Greater Manchester, UK.
  • Marzo-Ortega H; Faculty of Health and Education, Manchester Metropolitan University, Manchester, UK.
  • Murphy DJ; Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, UK.
  • Sandhu V; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Sengupta R; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Siebert S; Department of Rheumatology, Honiton Surgery, Royal Devon & Exeter Hospital, Exeter, UK.
  • Thompson B; Department of Rheumatology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Webb D; Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK.
  • Yates M; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
  • Gaffney K; Rheumatology Department, The Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
Rheumatol Adv Pract ; 7(2): rkad039, 2023.
Article em En | MEDLINE | ID: mdl-37197377
Pharmacological management has advanced considerably since the 2015 British Society for Rheumatology axial spondyloarthritis (axSpA) guideline to incorporate new classes of biologic DMARDs (bDMARDs, including biosimilars), targeted synthetic DMARDs (tsDMARDs) and treatment strategies such as drug tapering. The aim of this guideline is to provide an evidence-based update on pharmacological management of adults with axSpA (including AS and non-radiographic axSpA) using b/tsDMARDs. This guideline is aimed at health-care professionals in the UK who care directly for people with axSpA, including rheumatologists, rheumatology specialist nurses, allied health professionals, rheumatology specialty trainees and pharmacists; people living with axSpA; and other stakeholders, such as patient organizations and charities.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article